SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000093751-21-000289
Filing Date
2021-02-11
Accepted
2021-02-11 12:52:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 Bioxcel_Therapeutics_Inc.txt SC 13G 8524
  Complete submission text file 0000093751-21-000289.txt   10306
Mailing Address ONE LINCOLN STREET BOSTON MA 02111
Business Address ONE LINCOLN STREET BOSTON MA 02111 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

IRS No.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 6022 State Commercial Banks

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90437 | Film No.: 21618198
SIC: 2834 Pharmaceutical Preparations